Most Recent

image
Oct 1, 2026

The good, the bad and the grumpy: Will Joe Aston’s Rampart go soft on its corporate backers?

In this week’s On Background, Joe Aston’s media start-up has got everyone talking, the ABC seems bored with long news bulletins and ATO’s latest data once again reveals a sorry tale.

image
Oct 1, 2026

Unemployment probably does need to climb … for now

The Reserve Bank is not out to get people fired. But it needs to be careful about the direction it’s taking.

image
Oct 1, 2026

Trump’s ‘betrayal’ of America’s heartland will cost him

We are about to find out whether the American people are finally going to rein in the belligerent fabulist that they so recklessly unleashed a second time.

image
Oct 1, 2026

The hidden traps lurking in your office WhatsApp group

Every message you send contains potential dangers, and you should be across them all.

image
Oct 1, 2026

Critica adds global commodities clout to board

Critica has added global commodities specialist Hannah Badenach to its board, bringing key offtake and financing experience to its Mt Lindsay and Jupiter critical minerals projects.

image
Oct 1, 2026

Bonanza gold hits keep rolling for Aurum in West Africa

Aurum Resources has hit its best-ever gold intercept at the Boundiali project in West Africa, with a stunning 28.8m section grading 22.92g/t gold as it pushes towards a DFS.

image
Oct 1, 2026

Broken Hill bags remnant gold ahead of SA mine restart

Broken Hill Gold has poured an extra 174 gold ounces from its White Dam heap leach project in South Australia, with proceeds to fund the restart of mining at its Vertigo pit.

image
Oct 1, 2026

Fuel giant Ampol zooms past Tesla as Australia’s top EV charger owner

Australia’s top petrol and diesel supplier has raised its bet on the shift to EVs with a deal to triple the size of its fast-charging network.

image
Oct 1, 2026

CBA commits to cash and will keep hundreds of regional branches open until 2030

The two pledges come as foot traffic to branches and cash usage by Australians continues to fall.

image
Oct 1, 2026

NeuroScientific specialist hire sets stage for major Crohn’s trial

NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.